Ashika Credit Capital Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:36 pm

Quick Insight

Ashika Credit Capital Ltd, a Non-Banking Financial Company (NBFC), currently trades at ₹427 with a market capitalization of ₹1,631 Cr. The company's P/E ratio stands at -51, indicating negative earnings, while ROE and ROCE are at 20.2% and 22.1% respectively. Operating profit margin is at a concerning -2,904%, and the net profit is -51. With promoters holding a significant 60.27% stake and a high P/BV ratio of 4.10x, investors should closely monitor the company's ability to turn around its profitability and manage its borrowings, given the negative ICR of -7.82x.

Competitors of Ashika Credit Capital Ltd

All Competitor Stocks of Ashika Credit Capital Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:55 am

Below is a detailed analysis of the quarterly data for Ashika Credit Capital Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Dec 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Expenses, as of Mar 2025, the value is 70.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24.00 Cr. (Dec 2024) to 70.00 Cr., marking an increase of 46.00 Cr..
• For Operating Profit, as of Mar 2025, the value is -68.00 Cr.. The value appears to be declining and may need further review. It has decreased from -23.00 Cr. (Dec 2024) to -68.00 Cr., marking a decrease of 45.00 Cr..
• For OPM %, as of Mar 2025, the value is -2,904.00%. The value appears to be declining and may need further review. It has decreased from -1,741.00% (Dec 2024) to -2,904.00%, marking a decrease of 1,163.00%.
• For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Interest, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 3.00 Cr..
• For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -70.00 Cr.. The value appears to be declining and may need further review. It has decreased from -26.00 Cr. (Dec 2024) to -70.00 Cr., marking a decrease of 44.00 Cr..
• For Tax %, as of Mar 2025, the value is -23.00%. The value appears to be improving (decreasing) as expected. It has decreased from -22.00% (Dec 2024) to -23.00%, marking a decrease of 1.00%.
• For Net Profit, as of Mar 2025, the value is -54.00 Cr.. The value appears to be declining and may need further review. It has decreased from -20.00 Cr. (Dec 2024) to -54.00 Cr., marking a decrease of 34.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -16.27. The value appears to be declining and may need further review. It has decreased from -8.06 (Dec 2024) to -16.27, marking a decrease of 8.21.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:24 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:49 pm

Below is a detailed analysis of the balance sheet data for Ashika Credit Capital Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2024) to 33.00 Cr., marking an increase of 21.00 Cr..
• For Reserves, as of Mar 2025, the value is 407.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2024) to 407.00 Cr., marking an increase of 351.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 25.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 24.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 443.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 95.00 Cr. (Mar 2024) to 443.00 Cr., marking an increase of 348.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 341.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2024) to 341.00 Cr., marking an increase of 247.00 Cr..
• For Other Assets, as of Mar 2025, the value is 102.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 102.00 Cr., marking an increase of 101.00 Cr..
• For Total Assets, as of Mar 2025, the value is 443.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2024) to 443.00 Cr., marking an increase of 348.00 Cr..

Notably, the Reserves (407.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Ashika Credit Capital Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -25.76. This value is below the healthy minimum of 5. It has decreased from 9.01 (Mar 24) to -25.76, marking a decrease of 34.77.
• For Diluted EPS (Rs.), as of Mar 25, the value is -25.76. This value is below the healthy minimum of 5. It has decreased from 9.01 (Mar 24) to -25.76, marking a decrease of 34.77.
• For Cash EPS (Rs.), as of Mar 25, the value is -15.52. This value is below the healthy minimum of 3. It has decreased from 9.03 (Mar 24) to -15.52, marking a decrease of 24.55.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 132.97. It has increased from 57.30 (Mar 24) to 132.97, marking an increase of 75.67.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 132.97. It has increased from 57.30 (Mar 24) to 132.97, marking an increase of 75.67.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.28. It has decreased from 15.47 (Mar 24) to 1.28, marking a decrease of 14.19.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -17.83. This value is below the healthy minimum of 2. It has decreased from 11.38 (Mar 24) to -17.83, marking a decrease of 29.21.
• For PBIT / Share (Rs.), as of Mar 25, the value is -17.84. This value is below the healthy minimum of 0. It has decreased from 11.36 (Mar 24) to -17.84, marking a decrease of 29.20.
• For PBT / Share (Rs.), as of Mar 25, the value is -20.12. This value is below the healthy minimum of 0. It has decreased from 10.74 (Mar 24) to -20.12, marking a decrease of 30.86.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -15.53. This value is below the healthy minimum of 2. It has decreased from 9.01 (Mar 24) to -15.53, marking a decrease of 24.54.
• For PBDIT Margin (%), as of Mar 25, the value is -1,392.23. This value is below the healthy minimum of 10. It has decreased from 73.53 (Mar 24) to -1,392.23, marking a decrease of 1,465.76.
• For PBIT Margin (%), as of Mar 25, the value is -1,393.19. This value is below the healthy minimum of 10. It has decreased from 73.41 (Mar 24) to -1,393.19, marking a decrease of 1,466.60.
• For PBT Margin (%), as of Mar 25, the value is -1,571.17. This value is below the healthy minimum of 10. It has decreased from 69.41 (Mar 24) to -1,571.17, marking a decrease of 1,640.58.
• For Net Profit Margin (%), as of Mar 25, the value is -1,212.59. This value is below the healthy minimum of 5. It has decreased from 58.22 (Mar 24) to -1,212.59, marking a decrease of 1,270.81.
• For Return on Networth / Equity (%), as of Mar 25, the value is -11.67. This value is below the healthy minimum of 15. It has decreased from 15.72 (Mar 24) to -11.67, marking a decrease of 27.39.
• For Return on Capital Employeed (%), as of Mar 25, the value is -13.39. This value is below the healthy minimum of 10. It has decreased from 19.51 (Mar 24) to -13.39, marking a decrease of 32.90.
• For Return On Assets (%), as of Mar 25, the value is -11.59. This value is below the healthy minimum of 5. It has decreased from 11.27 (Mar 24) to -11.59, marking a decrease of 22.86.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.36 (Mar 24) to 0.00, marking a decrease of 0.36.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.23 (Mar 24) to 0.01, marking a decrease of 0.22.
• For Current Ratio (X), as of Mar 25, the value is 178.66. This value exceeds the healthy maximum of 3. It has increased from 3.67 (Mar 24) to 178.66, marking an increase of 174.99.
• For Quick Ratio (X), as of Mar 25, the value is 178.66. This value exceeds the healthy maximum of 2. It has increased from 3.67 (Mar 24) to 178.66, marking an increase of 174.99.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -7.82. This value is below the healthy minimum of 3. It has decreased from 18.41 (Mar 24) to -7.82, marking a decrease of 26.23.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -5.81. This value is below the healthy minimum of 3. It has decreased from 15.58 (Mar 24) to -5.81, marking a decrease of 21.39.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,796.57. It has increased from 105.65 (Mar 24) to 1,796.57, marking an increase of 1,690.92.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 423.68. This value exceeds the healthy maximum of 3. It has increased from 5.75 (Mar 24) to 423.68, marking an increase of 417.93.
• For EV / EBITDA (X), as of Mar 25, the value is -30.43. This value is below the healthy minimum of 5. It has decreased from 7.82 (Mar 24) to -30.43, marking a decrease of 38.25.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 425.46. This value exceeds the healthy maximum of 3. It has increased from 4.41 (Mar 24) to 425.46, marking an increase of 421.05.
• For Price / BV (X), as of Mar 25, the value is 4.10. This value exceeds the healthy maximum of 3. It has increased from 1.19 (Mar 24) to 4.10, marking an increase of 2.91.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 425.70. This value exceeds the healthy maximum of 3. It has increased from 4.41 (Mar 24) to 425.70, marking an increase of 421.29.
• For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to -0.02, marking a decrease of 0.15.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness